Yujiro Ito

发表

Third-line hormonal therapy to treat prostate cancer relapse after initial and second-line hormonal therapy: report of 52 cases and literature review.

Kazuhiro Matsumoto, N. Hayakawa, N. Tanaka, 2014, Asian Pacific journal of cancer prevention : APJCP.

Comparison of transurethral enucleation with bipolar and transurethral resection in saline for managing benign prostatic hyperplasia

H. Ide, Y. Hirasawa, Y. Yasumizu, 2012, BJU international.

Extensive disease among potential candidates for hemi‐ablative focal therapy for prostate cancer

P. Scardino, J. Eastham, H. Vargas, 2019, International journal of urology : official journal of the Japanese Urological Association.

A prospective longitudinal survey of erectile function status in symptomatic benign prostatic hyperplasia patients treated with dutasteride

E. Kikuchi, A. Miyajima, M. Oya, 2016, The aging male : the official journal of the International Society for the Study of the Aging Male.

Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

E. Suzuki, E. Kikuchi, A. Miyajima, 2015, BMC Cancer.

Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model.

K. Nakagawa, M. Oya, M. Oyama, 2017, Urologic oncology.

Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings.

K. Nakagawa, M. Oya, M. Oyama, 2016, Urologic oncology.

Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy.

K. Nakagawa, M. Oya, M. Oyama, 2019, Japanese journal of clinical oncology.

Evaluation of histopathological findings at the injection site following degarelix administration

M. Oya, T. Kosaka, N. Hayakawa, 2015, Supportive Care in Cancer.

Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients

E. Kikuchi, A. Miyajima, M. Oya, 2016, Annals of Surgical Oncology.

Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

E. Suzuki, E. Kikuchi, A. Miyajima, 2015, BMC Cancer.

The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.

K. Nakagawa, E. Kikuchi, A. Miyajima, 2014, European urology.

Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer

P. Scardino, J. Eastham, V. Reuter, 2019, The Journal of urology.

External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study.

K. Nakagawa, M. Oya, M. Oyama, 2016, European urology focus.

Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis.

N. Hayakawa, N. Tanaka, N. Niwa, 2015, Urologic oncology.

The combination therapy of prednisolone and tacrolimus for severe painful bladder syndrome/interstitial cystitis.

K. Nishimoto, Yujiro Ito, G. Kaneko, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.

M. Jinzaki, E. Kikuchi, A. Miyajima, 2011, The Journal of urology.

Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy.

M. Jinzaki, E. Kikuchi, A. Miyajima, 2012, Japanese journal of clinical oncology.

Renal cell carcinoma arising from a horseshoe kidney in a chronic hemodialysis patient

K. Nakagawa, E. Kikuchi, A. Miyajima, 2012, Clinical and Experimental Nephrology.

Female Functional Constipation Is Associated with Overactive Bladder Symptoms and Urinary Incontinence

N. Tsukada, S. Funakoshi, A. Nakazawa, 2017, BioMed research international.

[Two cases of urinary retention secondary to benign inflammatory nervous diseases].

Yujiro Ito, Yasumitsu Uchida, F. Nakajima, 2009, Hinyokika kiyo. Acta urologica Japonica.

In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence

P. Scardino, J. Eastham, V. Reuter, 2019, American Journal of Surgical Pathology.

Isolated cervical lymph node metastasis of renal pelvic squamous cell carcinoma: A case report.

H. Ide, Y. Hirasawa, Yujiro Ito, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Characterizing intermediate-risk non-muscle-invasive bladder cancer: Implications for the definition of intermediate risk and treatment strategy.

E. Kikuchi, A. Miyajima, M. Oya, 2017, Urologic oncology.

Impact of Second-Line Targeted Therapy Dose Intensity on Patients With Metastatic Renal Cell Carcinoma.

K. Nakagawa, M. Oya, M. Oyama, 2016, Clinical genitourinary cancer.

Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma

K. Nakagawa, M. Oya, M. Oyama, 2018, Japanese journal of clinical oncology.

Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy.

M. Jinzaki, E. Kikuchi, A. Miyajima, 2012, Japanese Journal of Clinical Oncology.